Regulatory changes, market factors and aligning commercial strategies are all factors that pharma firms must consider when updating or implementing process and technologies. In a round-table with Manufacturing Chemist, our senior product manager, Ben Wylie, discusses the importance of effective aseptic processing measures to protect drug products from contamination and the use of smart monitoring technologies to reliably understand the health status of processes and devices.
